Td Private Client Wealth LLC Alnylam Pharmaceuticals, Inc. Transaction History

Td Private Client Wealth LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Aug 16, 2024	SELL	$170.77 - $211.65 $1,536 - $1,904	-9 Closed	0 $0
Q1 2022 Aug 16, 2024	SELL	$127.18 - $173.91 $763 - $1,043	-6 Reduced 40.0%	9 $1.47 Million
Q4 2021 Aug 16, 2024	SELL	$159.56 - $209.29 $2,872 - $3,767	-18 Reduced 54.55%	15 $2.54 Million
Q3 2021 Aug 16, 2024	BUY	$169.75 - $207.73 $5,601 - $6,855	33 New	33 $6.23 Million
Q4 2020 Aug 16, 2024	SELL	$122.97 - $147.0 $5,533 - $6,615	-45 Reduced 57.69%	33 $4.29 Million
Q1 2020 Aug 16, 2024	BUY	$93.12 - $133.99 $279 - $401	3 Added 4.0%	78 $8.49 Million
Q4 2019 Aug 16, 2024	BUY	$74.51 - $124.23 $5,588 - $9,317	75 New	75 $8.64 Million

642

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Td Private Client Wealth LLC with notifications on news.